BrainAurora Medical's Schizophrenia Study Results Published in International Journal

MT Newswires Live
09/02

BrainAurora Medical Technology (HKG:6681) has published the clinical research results titled "Randomized trial of self-adaptive computerized cognitive remediation in schizophrenia" in international academic journal npj Digital Medicine.

The clinical study was jointly conducted by the company, and Professor Wang Gang's team at Beijing Anding Hospital, Capital Medical University, according to a Wednesday Hong Kong bourse filing.

The study showed that self-adaptive cognitive training can boost and expedite cognitive improvement in patients with schizophrenia, particularly in the areas of attention and processing speed.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10